These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 10340539
1. The effects of intravenous naltrindole and naltrindole 5'-isothiocyanate on sufentanil-induced respiratory depression and antinociception in rats. Verborgh C, Meert TF. Pharmacol Biochem Behav; 1999 May; 63(1):175-83. PubMed ID: 10340539 [Abstract] [Full Text] [Related]
2. Antagonistic effects of naloxone and naloxonazine on sufentanil-induced antinociception and respiratory depression in rats. Verborgh C, Meert TF. Pain; 1999 Oct; 83(1):17-24. PubMed ID: 10506668 [Abstract] [Full Text] [Related]
6. Sufentanil-related respiratory depression and antinociception in the dog. Mediation by different receptor types. Latasch L, Freye E. Arzneimittelforschung; 2002 Oct; 52(12):870-6. PubMed ID: 12572526 [Abstract] [Full Text] [Related]
7. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine. Calcagnetti DJ, Holtzman SG. Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444 [Abstract] [Full Text] [Related]
8. Alkylation of opioid receptors by 5'-naltrindole-isothiocyanate injected into the nucleus accumbens of rats: receptor selectivity and anatomical diffusion. Martin TJ, McIntosh S, Smith JE. Synapse; 2006 Oct; 60(5):384-91. PubMed ID: 16847946 [Abstract] [Full Text] [Related]
10. Interaction between sufentanil and U-50488H with respect to antinociception and respiratory depression in rats. Verborgh CM, Camu F, Meert TF. Acta Anaesthesiol Scand; 1997 Aug; 41(7):895-902. PubMed ID: 9265934 [Abstract] [Full Text] [Related]
11. Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice. Suzuki T, Tsuji M, Mori T, Misawa M, Nagase H. Pharmacol Biochem Behav; 1997 Aug; 57(1-2):293-9. PubMed ID: 9164585 [Abstract] [Full Text] [Related]
14. Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to mu and kappa agonists in rats. Fernández B, Antelo MT, Kitchen I, Viveros MP. Pharmacol Biochem Behav; 1999 Jan; 62(1):145-9. PubMed ID: 9972857 [Abstract] [Full Text] [Related]
17. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes. Jiang Q, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F. J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319 [Abstract] [Full Text] [Related]
18. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord. Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF. J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378 [Abstract] [Full Text] [Related]
19. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats. Pavlovic ZW, Cooper ML, Bodnar RJ. Brain Res; 1996 Nov 25; 741(1-2):13-26. PubMed ID: 9001699 [Abstract] [Full Text] [Related]
20. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats. Crook TJ, Kitchen I, Hill RG. Br J Pharmacol; 1992 Oct 25; 107(2):573-6. PubMed ID: 1330187 [Abstract] [Full Text] [Related] Page: [Next] [New Search]